HCC-neuroendocrine transition: Tumor plasticity under immunotherapy
Gastroenterol Hepatol. 2022 Aug-Sep;45(7):552-554.
doi: 10.1016/j.gastrohep.2022.01.008.
Epub 2022 Feb 2.
[Article in
English,
Spanish]
Affiliations
- 1 BCLC Group, Liver Unit, Hospital Clínic of Barcelona, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain.
- 2 BCLC Group, Department of Pathology, Hospital Clinic of Barcelona, IDIBAPS, CIBERehd, University of Barcelona, Spain.
- 3 BCLC Group, Liver Unit, Hospital Clínic of Barcelona, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain. Electronic address: mreig1@clinic.cat.
- 4 BCLC Group, Department of Pathology, Hospital Clinic of Barcelona, IDIBAPS, CIBERehd, University of Barcelona, Spain. Electronic address: madiaz@clinic.cat.
No abstract available
MeSH terms
-
Carcinoma, Hepatocellular* / pathology
-
Carcinoma, Hepatocellular* / therapy
-
Humans
-
Immunologic Factors
-
Immunotherapy
-
Liver Neoplasms* / pathology
-
Liver Neoplasms* / therapy